Menu

FastWave Artero

TM

Advanced IVL for
Peripheral Artery Disease

FastWave Sola

TM

Next-Gen IVL for
Coronary Artery Disease

Menu

FastWave Artero

TM

Advanced IVL for
Peripheral Artery Disease

FastWave Sola

TM

Next-Gen IVL for

Coronary Artery Disease

FastWave Artero

TM

Advanced IVL for
Peripheral Artery Disease

FastWave Sola

TM

Next-Gen IVL for

Coronary Artery Disease

Our fast-moving team is developing intravascular lithotripsy (IVL) systems for calcific artery disease, a huge unmet need for patients, and a market valued at over $10B.

Our fast-moving team is developing intravascular lithotripsy (IVL) systems for calcific artery disease, a huge unmet need for patients, and a market valued at over $10B.

Our fast-moving team is developing intravascular lithotripsy (IVL) systems for calcific artery disease, a huge unmet need for patients, and a market valued at over $10B.

Balloon catheter platform designed for challenging anatomy.

Easy-to-use system with valuable procedural feedback.

Predictable sonic output with increased pulse availability.

See What the Experts Say

See What the Experts Say

See What the Experts Say

  • "FastWave’s IVL platforms show incredible promise for calcific disease."

    Dr. Art Lee

    Interventional Cardiologist

  • "IVL is a phenomenal therapy and FastWave’s systems are very impressive."

    Dr. Peter Schneider

    Vascular Surgeon

  • "I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."

    Dr. Amir Kaki

    Interventional Cardiologist

  • "FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."

    Dr. Miguel Montero-Baker

    Vascular Surgeon

  • "FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."

    Dr. Venkatesh Ramaiah

    Vascular Surgeron

  • "I’m excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability."

    Dr. Raj Dave

    Interventional Cardiologist

  • "FastWave’s novel approach has enormous potential to leapfrog today’s IVL technology with durable, fast, and consistent laser energy."

    Dr. William Nicholson

    Interventional Cardiologist

  • "FastWave Medical’s novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse."

    Dr. Kathleen Kearney

    Interventional Cardiologist

  • "FastWave’s IVL platforms show incredible promise for calcific disease."

    Dr. Art Lee

    Interventional Cardiologist

  • "IVL is a phenomenal therapy and FastWave’s systems are very impressive."

    Dr. Peter Schneider

    Vascular Surgeon

  • "I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."

    Dr. Amir Kaki

    Interventional Cardiologist

  • "FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."

    Dr. Miguel Montero-Baker

    Vascular Surgeon

  • "FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."

    Dr. Venkatesh Ramaiah

    Vascular Surgeron

  • "I’m excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability."

    Dr. Raj Dave

    Interventional Cardiologist

  • "FastWave’s novel approach has enormous potential to leapfrog today’s IVL technology with durable, fast, and consistent laser energy."

    Dr. William Nicholson

    Interventional Cardiologist

  • "FastWave Medical’s novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse."

    Dr. Kathleen Kearney

    Interventional Cardiologist

  • "FastWave’s IVL platforms show incredible promise for calcific disease."

    Dr. Art Lee

    Interventional Cardiologist

  • "IVL is a phenomenal therapy and FastWave’s systems are very impressive."

    Dr. Peter Schneider

    Vascular Surgeon

  • "I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."

    Dr. Amir Kaki

    Interventional Cardiologist

  • "FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."

    Dr. Miguel Montero-Baker

    Vascular Surgeon

  • "FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."

    Dr. Venkatesh Ramaiah

    Vascular Surgeron

  • "I’m excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability."

    Dr. Raj Dave

    Interventional Cardiologist

  • "FastWave’s novel approach has enormous potential to leapfrog today’s IVL technology with durable, fast, and consistent laser energy."

    Dr. William Nicholson

    Interventional Cardiologist

  • "FastWave Medical’s novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse."

    Dr. Kathleen Kearney

    Interventional Cardiologist

  • "FastWave Medical’s novel IVL platforms offer genuine promise for addressing severely calcified coronary arteries that are difficult to traverse."

    Dr. Kathleen Kearney

    Interventional Cardiologist

  • "FastWave’s team has rapidly-developed an easy-to-use system to address existing technological gaps."

    Dr. Miguel Montero-Baker

    Vascular Surgeon

  • "I’m excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability."

    Dr. Raj Dave

    Interventional Cardiologist

  • "FastWave’s IVL technology is a promising advancement in calcium modification and I’m excited by their success."

    Dr. Venkatesh Ramaiah

    Vascular Surgeron

  • "IVL is a phenomenal therapy and FastWave’s systems are very impressive."

    Dr. Peter Schneider

    Vascular Surgeon

  • "FastWave’s IVL platforms show incredible promise for calcific disease."

    Dr. Art Lee

    Interventional Cardiologist

  • "I’m a big believer in IVL and couldn’t be more excited about FastWave’s systems."

    Dr. Amir Kaki

    Interventional Cardiologist

  • "FastWave’s novel approach has enormous potential to leapfrog today’s IVL technology with durable, fast, and consistent laser energy."

    Dr. William Nicholson

    Interventional Cardiologist

FastWave’s IVL Platforms Deliver
Promising Early Results

Selected Peripheral FIH Cases

Explore case studies showcasing the impact of our IVL technology in patients with calcified peripheral artery disease.

Coronary Pre-Clinical Evidence

Our coronary system demonstrates superior calcium fracture efficiency, leading to optimal vessel expansion and luminal gain.

Empowering Physicians with Advanced Tools for Calcific Artery Disease

Empowering Physicians with Advanced Tools for Calcific Artery Disease

Empowering Physicians with Advanced Tools for Calcific Artery Disease

Empowering Physicians with Advanced Tools for Calcific Artery Disease

Invest in the Future of IVL

We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.

$40M+ raised from corporate venture, VC, and KOLs.

100% lesions crossed in successful first-in-human study.

Only market incumbent acquired in 2024 by J&J for $13B.

Invest in the Future of IVL

We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.

$40M+ raised from corporate venture, VC, and KOLs.

100% lesions crossed in successful first-in-human study.

Only market incumbent acquired in 2024 by J&J for $13B.

Invest in the Future of IVL

We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.

$40M+ raised from corporate venture, VC, and KOLs.

100% lesions crossed in successful first-in-human study.

Only market incumbent acquired in 2024 by J&J for $13B.

Invest in the Future of IVL

We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.

$40M+ raised from corporate venture, VC, and KOLs.

100% lesions crossed in successful first-in-human study.

Only market incumbent acquired in 2024 by J&J for $13B.

Follow FastWave's Journey

Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.

© 2025 FastWave Medical Inc.

FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.

Follow FastWave's Journey

Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.

© 2025 FastWave Medical Inc.

FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.

Follow FastWave's Journey

Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.

© 2025 FastWave Medical Inc.

FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.

Follow FastWave's Journey

Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.

© 2025 FastWave Medical Inc.

FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.